INDUSTRY × Pharyngeal Neoplasms × Clear all
NCT04028479 2024-12-18

ROOT

Taproot Health

Completed
167 enrolled
NCT03769467 2024-11-14

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Atara Biotherapeutics

Phase 1/2 Terminated
12 enrolled 8 charts